Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Cruse Michael
Chief Operating Officer at OnKure Therapeutics. Filing since 25 Aug 2021.
CIK 0001854179
Company
Date
Role
Action
Shares
Amount
Of holding
OKUR
OnKure Therapeutics, Inc.
1 Sep 2022
Chief Operating Officer
Bought
7,500
$25.45K
121%
OKUR
OnKure Therapeutics, Inc.
31 Aug 2022
Chief Operating Officer
Bought
3,212
$10.31K
108%
OKUR
OnKure Therapeutics, Inc.
30 Aug 2022
Chief Operating Officer
Bought
1,845
$5.89K
162%
OKUR
OnKure Therapeutics, Inc.
30 Aug 2022
Chief Operating Officer
Bought
975
$3.08K
3.2%
OKUR
OnKure Therapeutics, Inc.
29 Aug 2022
Chief Operating Officer
Bought
1,140
$3.69K
opened
OKUR
OnKure Therapeutics, Inc.
29 Aug 2022
Chief Operating Officer
Bought
83
$268.92
0.3%
OKUR
OnKure Therapeutics, Inc.
25 Aug 2021
Senior VP-Corporate Operations
Bought
2,500
$18.62K
opened
7 decisions on file.
